BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22417064)

  • 1. Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model.
    Ng CS; Waterton JC; Kundra V; Brammer D; Ravoori M; Han L; Wei W; Klumpp S; Johnson VE; Jackson EF
    Technol Cancer Res Treat; 2012 Jun; 11(3):279-88. PubMed ID: 22417064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of DCE-MRI biomarker values on analysis algorithm.
    Ng CS; Wei W; Bankson JA; Ravoori MK; Han L; Brammer DW; Klumpp S; Waterton JC; Jackson EF
    PLoS One; 2015; 10(7):e0130168. PubMed ID: 26208254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculature.
    Jia ZZ; Shi W; Shi JL; Shen DD; Gu HM; Zhou XJ
    Eur J Radiol; 2017 Feb; 87():120-124. PubMed ID: 28034567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis.
    Bisdas S; Konstantinou GN; Lee PS; Thng CH; Wagenblast J; Baghi M; Koh TS
    Phys Med Biol; 2007 Oct; 52(20):6181-96. PubMed ID: 17921579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explanations for the heterogeneity of splenic enhancement derived from blood flow kinetic measurements using dynamic contrast-enhanced CT (DCE-CT).
    Sauter AW; Spira D; Schulze M; Horger MS
    Acta Radiol; 2014 Jul; 55(6):645-53. PubMed ID: 24005563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
    Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
    J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving quantitative CT perfusion parameter measurements using principal component analysis.
    Yeung TP; Dekaban M; De Haan N; Morrison L; Hoffman L; Bureau Y; Chen X; Yartsev S; Bauman G; Lee TY
    Acad Radiol; 2014 May; 21(5):624-32. PubMed ID: 24703475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
    Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
    Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application on the quantitative perfusion parameters of dynamic contrast-enhanced MRI in the pathological subtype of uterine leiomyoma].
    Zheng J; Zhao ZH; Yang JF; Zhao L; Yang LM; Hu HJ
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1155-1159. PubMed ID: 28427122
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical application of dynamic contrast-enhanced CT (DCE-CT) in patients with variously differentiated breast ductal carcinoma.
    Ma ZB; Ge FQ; Wang WX; Sun ZQ
    J Xray Sci Technol; 2018; 26(6):977-986. PubMed ID: 30198882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
    Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
    Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer.
    Bakke KM; Grøvik E; Meltzer S; Negård A; Holmedal SH; Mikalsen LTG; Lyckander LG; Ree AH; Gjesdal KI; Redalen KR; Bjørnerud A
    J Magn Reson Imaging; 2019 Oct; 50(4):1114-1124. PubMed ID: 30945379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
    Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM
    NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
    Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
    Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
    Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of CT perfusion parameters in liver tumors and normal liver.
    Ng CS; Chandler AG; Wei W; Herron DH; Anderson EF; Kurzrock R; Charnsangavej C
    Radiology; 2011 Sep; 260(3):762-70. PubMed ID: 21788525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of scan time on perfusion and flow extraction product (K-trans) measurements in lung cancer using low-dose volume perfusion CT (VPCT).
    Spira D; Gerlach JD; Spira SM; Schulze M; Sauter A; Horger M
    Acad Radiol; 2012 Jan; 19(1):78-83. PubMed ID: 22054806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.